| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |